With an under-vaccinated continent, and a fifth wave said to be looming, it’s hard to believe that SA’s first Covid-19 vaccination plant risks being shut down due to not receiving a single order.
Applauded as a lifesaver for South Africa and the rest of the African continent, Aspen Pharmacare negotiated a licensing deal in November of last year to package and sell Johnson & Johnson's Covid-19 vaccine and distribute it across Africa.
South Africa has vaccinated a mere 30% of its population.
Read the full article https://www.engineeringnews.co.za/article/aspen-covid-19-vaccine-plant-risks-closure-after-no-orders-executive-2022-05-0
